A

Antoni van Leeuwenhoek

Combines research and specialist cancer care

Overview

Antoni van Leeuwenhoek (AVL) combines cancer care with scientific research in one institution, acting as both a hospital and a research center. It provides diagnosis, treatment, and follow-up for cancer patients and conducts studies to improve therapies, supported by a multidisciplinary team of clinicians, researchers, and staff. Its strength comes from a long-standing integrated model and a national reputation for oncology, coupled with a collaborative, people-focused culture. The goal is to improve cancer treatment and patient outcomes by linking advanced research with high-quality clinical care, while growing the organization and developing its staff.

Work here?Claim your company

About Antoni van Leeuwenhoek

Simplify's Rating
Why Antoni van Leeuwenhoek is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

BiotechnologyHealthcare

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Netherlands

Founded

1913

Get referred to Antoni van Leeuwenhoek

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • AVL reported CZO accreditation success on 14 July 2026, reinforcing training quality.
  • On 7 July 2026, SUBITO data backed less burdensome treatment for high-risk breast cancer.
  • Its 2026 alliance with Tergooi MC expands surgeon capacity and regional patient reach.

What critics are saying

  • Dutch reimbursement pressure threatens margins as AVL itself demanded stricter drug value testing on 10 June 2026.
  • Referrals depend on maintaining elite outcomes; a quality slip would quickly shift complex cases elsewhere.
  • A public-sector talent squeeze would cripple research and specialist care faster than competitors.

What makes Antoni van Leeuwenhoek unique

  • Antoni van Leeuwenhoek combines cancer care, research, and trials in one specialist institution.
  • Its 2026 AI treatment-response model and MR-linac work show real clinical depth.
  • The institute still shapes Dutch oncology standards through visible national advocacy and publications.

Help us improve and share your feedback! Did you find this helpful?

Recently Posted Jobs

Sign up to get curated job recommendations

Antoni van Leeuwenhoek is Hiring for 45 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs